Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141443 |
| CAS No | NA |
| Mol.F. | C31H35N9O6 |
| Mol.Wt. | 614.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141444 |
| CAS No | NA |
| Mol.F. | C31H36N8O5 |
| Mol.Wt. | 600.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141445 |
| CAS No | NA |
| Mol.F. | C31H35N9O6 |
| Mol.Wt. | 629.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141446 |
| CAS No | NA |
| Mol.F. | C30H32N10O7 |
| Mol.Wt. | 644.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141447 |
| CAS No | NA |
| Mol.F. | C31H35N9O6 |
| Mol.Wt. | 629.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141448 |
| CAS No | 1216985-81-7 |
| Mol.F. | C18H38N2O |
| Mol.Wt. | 298.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141449 |
| CAS No | NA |
| Mol.F. | C14H12N4O5S2 |
| Mol.Wt. | 380.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141450 |
| CAS No | NA |
| Mol.F. | C12H16N4O2 |
| Mol.Wt. | 248.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141451 |
| CAS No | NA |
| Mol.F. | C16H18N2O5 |
| Mol.Wt. | 318.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141452 |
| CAS No | NA |
| Mol.F. | C15H18Cl2N4O5 |
| Mol.Wt. | 405.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141453 |
| CAS No | NA |
| Mol.F. | C27H31FN10O3 |
| Mol.Wt. | 562.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141454 |
| CAS No | NA |
| Mol.F. | C26H23N7O3 |
| Mol.Wt. | 481.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141455 |
| CAS No | NA |
| Mol.F. | C26H23N7O3 |
| Mol.Wt. | 481.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141456 |
| CAS No | NA |
| Mol.F. | C33H34F4N4O3 |
| Mol.Wt. | 610.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141457 |
| CAS No | NA |
| Mol.F. | C14H20N6O4S |
| Mol.Wt. | 368.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141458 |
| CAS No | NA |
| Mol.F. | C13H18N6O4S |
| Mol.Wt. | 354.4 |
| INV STATUS | CUSTOM SYNTHESIS |